Excavate the role of E2F family in the prognosis, drug sensitivity analyses, and Immune cell infiltration of KIRC (Kidney Clear Cell Carcinoma)
Research Square
2022
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
KIRC is a common malignant tumor with few early symptoms, usually been found and diagnosed when it becomes large with hematuria, kidney injury and abdominal mass. E2F family include 8 genes (E2F1, E2F2, E2F3, E2F4, E2F5, E2F6, E2F7 and E2F8) and express high in virtually all cancers. Their role in cell proliferation has been extensively studied. Regrettably, there are very few reports about the interrelationship between KIRC and E2Fs. In order to research their relation, by taking great advantage of some reliable datasets and bioinformaticsx tools, we excavated the expression level of E2Fs, the prognostic value of E2Fs in KIRC, co-expression network, drug sensitivity analysis, kinase target and immune cell infiltration of E2Fs in KIRC patient. Our work may provide new insights into the selection of immunotherapeutic targets and prognostic biomarkers for KIRC. It also provides more data to help clinicians select appropriate therapeutic agents and more accurately predict the long-term prognosis of patients with renal cancer.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know